Validation of hemoglobin measurement in venous blood using HemoCue for the Ensanut 2022.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2023-11-13 DOI:10.21149/15063

Vanessa De la Cruz-Góngora, Ignacio Méndez-Gómez Humarán, Socorro Jaimes-Terán, Miguel Gaytán, Luz María Gómez-Acosta, Norma Isela Vizuet-Vega, Elsa Berenice Gaona-Pineda, Lucia Cuevas-Nasu, Martín Romero, Omar Dary, Teresa Shamah-Levy

{"title":"Validation of hemoglobin measurement in venous blood using HemoCue for the Ensanut 2022.","authors":"Vanessa De la Cruz-Góngora, Ignacio Méndez-Gómez Humarán, Socorro Jaimes-Terán, Miguel Gaytán, Luz María Gómez-Acosta, Norma Isela Vizuet-Vega, Elsa Berenice Gaona-Pineda, Lucia Cuevas-Nasu, Martín Romero, Omar Dary, Teresa Shamah-Levy","doi":"10.21149/15063","DOIUrl":null,"url":null,"abstract":"Objective: To validate hemoglobin (Hb) concentration in venous blood (VB) using the HemoCue 201+ in a subsample of children and women from the Mexican National Health and Nutrition Survey 2022.Materials and methods: Prior to field work 50 HemoCue 201+ devices were verified using venous blood. During the field work 57 children (aged 1-11) and 62 women (aged 12-49) donated 3 mL of VB each. Hb was measured in each device of HemoCue 201+ and in a hematologic autoanalyzer for the validation.Results: No significant bias was found in most of the devices. An adjustment criterion was used for 22 devices. Hb mean difference results were -0.049±0.578 g/dL in children and -0.098±0.628 g/dL in women.Conclusions: The HemoCue 201+ is a valid tool for estimating Hb concentration to produce reliable estimates of anemia prevalence when using venous blood.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21149/15063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To validate hemoglobin (Hb) concentration in venous blood (VB) using the HemoCue 201+ in a subsample of children and women from the Mexican National Health and Nutrition Survey 2022.

Materials and methods: Prior to field work 50 HemoCue 201+ devices were verified using venous blood. During the field work 57 children (aged 1-11) and 62 women (aged 12-49) donated 3 mL of VB each. Hb was measured in each device of HemoCue 201+ and in a hematologic autoanalyzer for the validation.

Results: No significant bias was found in most of the devices. An adjustment criterion was used for 22 devices. Hb mean difference results were -0.049±0.578 g/dL in children and -0.098±0.628 g/dL in women.

Conclusions: The HemoCue 201+ is a valid tool for estimating Hb concentration to produce reliable estimates of anemia prevalence when using venous blood.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

使用 Ensanut 2022 HemoCue 验证静脉血中的血红蛋白测量。

目的在 2022 年墨西哥全国健康与营养调查的儿童和妇女子样本中使用 HemoCue 201+ 验证静脉血（VB）中的血红蛋白（Hb）浓度：在实地考察之前，使用静脉血对 50 台 HemoCue 201+ 设备进行了验证。在实地工作期间，57 名儿童（1-11 岁）和 62 名妇女（12-49 岁）分别捐献了 3 毫升静脉血。每个 HemoCue 201+ 设备和一台血液自动分析仪都测量了血红蛋白，以进行验证：结果：大多数设备未发现明显偏差。对 22 台设备采用了调整标准。儿童和妇女的血红蛋白平均差分别为-0.049±0.578 g/dL和-0.098±0.628 g/dL：结论：HemoCue 201+ 是估算 Hb 浓度的有效工具，可在使用静脉血时可靠地估算贫血患病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊